Tag: DEP oncology drug
Starpharma inks second deal with global pharmaceutical giant
Australian company Starpharma has signed a milestone deal with global pharmaceutical giant AstraZeneca to further develop a Dendrimer Enhanced Product (DEP) version of one...
Featured Article
What spending reveals about downstream consumer demand for manufactured goods
For manufacturers supplying consumer-facing markets, understanding demand conditions has become increasingly important in an environment shaped by cautious spending, rising costs and intense competition.
